M. SCOTT SALKA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Armata Pharmaceuticals, Inc.

Filing Date Source Excerpt
2015-07-10 M. Scott Salka was appointed as Chief Executive Officer and a Class III director on May 18, 2015. Mr. Salka's term as a director will expire at the 2015 annual meeting of stockholders.
2016-05-20 The following table sets forth information for our current directors: Name Age Position M. Scott Salka 54 Chief Executive Officer, Director

Data sourced from SEC filings. Last updated: 2026-02-03